Medelis
offers supplemental oncology clinical development services for pharmaceutical and biotech companies... Read moreMedelis
offers supplemental oncology clinical development services for pharmaceutical and biotech companies... Read more
News
May 26, 2026
Medelis Blog
Medelis Blog What ASCO 2026's "Translation" Theme Actually Means When You're Running a Phase I Oncology Trial
Feb 04, 2026
Medelis Blog
Medelis Blog 2026 Oncology Drug Development Planning Realities
Dec 17, 2025
Medelis Blog
Medelis Blog What BIO Europe 2025 Revealed About the Future of Phase I and II Oncology Trials
Oct 09, 2025
Medelis Blog
Medelis Blog BIO Europe 2025 in Vienna
Jul 18, 2025
Medelis Blog
Medelis Blog BIO 2025 Boston: Key Takeaways for Clinical Development Teams
May 18, 2025
Medelis Blog
Medelis Blog ASCO 2025 - Let's Talk About What's Next in Oncology
Mar 12, 2025
Medelis Blog
Medelis Blog How AI is Transforming New Drug Discovery
Oct 25, 2024
Medelis Blog
Medelis Blog Preparing for Your Targeted Treatment in the Clinic
Jun 20, 2024
Medelis Blog
Medelis Blog ASCO 2024 - Takeaways from Five Key Studies
May 08, 2024
Medelis Blog
Medelis Blog Harnessing the Power of Innovation and Collaboration: Key Takeaways ASCO 2024
Medelis Competitors
1
2
3
4
5
6
7
8
9
10